Moreover, we obtained evidence that the I2558 M mutation promotes tau hyper‐phosphorylation specifically at the S396 and S404 sites as indicated by results from ICC, ELISA, Western blotting, and tau PTMs. This evidence concerns the gene MAPT and intrahepatic cholangiocarcinoma.